On 3/31/25, Corcept Therapeutics Inc (NASDAQ: CORT) stock enjoyed a major increase of 109.1%, closing at $114.22. Moreover, exceptionally high trading volume at 1069% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 94.7% during the last week.
Current PriceTarget Research Rating
Corcept Therapeutics has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Corcept Therapeutics has a poor Appreciation Score of 23 but a very high Power Rating of 86, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment